Iovance Biotherapeutics (IOVA)
(Delayed Data from NSDQ)
$8.73 USD
+0.29 (3.44%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $8.72 -0.01 (-0.11%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Brokerage Reports
Iovance Biotherapeutics, Inc. [IOVA]
Reports for Purchase
Showing records 181 - 187 ( 187 total )
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
3Q17 Results; Second Star to the Right and Straight on TIL Morning; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Shout Out to WuXi; Iovance in Good Hands; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Targeting Liquid Tumors and Automating the Supply Chain; Iovance Expanding on Multiple Fronts
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Pins Set Up: Kite Acquired and Kymriah Approved; TILs Can Knock ''Em Down; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Cervical Study Gets Underway as Push Continues for Solid Tumor Differentiation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2Q17 Results; New Name but Still Roaring; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2Q17 Results; New Name but Still Roaring; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.